Impact of cigarette smoke on pulmonary vein and artery volumes in those with current and former smoking status: a quantitative computed tomography analysis
<b>Cigarette smoking is related to increased small pulmonary vein and artery volumes. These findings highlight the potential of CT imaging to assess smoking-related vascular changes in diseases like COPD and pulmonary hypertension.</b> https://bit.ly/4ljnU6q.
Authors
- Pim A. de Jong (ORCID: https://orcid.org/0000-0003-4840-6854)
- Firdaus A. A. Mohamed Hoesein (ORCID: https://orcid.org/0000-0003-2536-9384)
- David A. Lynch (ORCID: https://orcid.org/0000-0002-6329-2325)
- Wouter A. C. van Amsterdam (ORCID: https://orcid.org/0000-0002-3181-0810)
- James D. Crapo (ORCID: https://orcid.org/0000-0002-1262-5230)
- Anastasia K. A. L. Kwee (ORCID: https://orcid.org/0000-0002-9056-1885)
- Richard Casaburi (ORCID: https://orcid.org/0000-0002-8851-8589)
- Leticia Gallardo-Estrella (ORCID: https://orcid.org/0000-0003-3446-2687)
- Stephen M. Humphries (ORCID: https://orcid.org/0000-0002-5113-4530)
- Harm A.W.M. Tiddens (ORCID: https://orcid.org/0000-0001-5628-6667)
- Esther Pompe (ORCID: https://orcid.org/0000-0002-1749-0208)
- Jean‐Paul Charbonnier
Institutions
- Utrecht University (NL)
- Boiron (France) (FR)
- UCLA Medical Center (US)
- University Medical Center Utrecht (NL)
- National Jewish Health (US)
- Nijmegen Institute for Scientist Practitioners in Addiction (NL)
- Harbor–UCLA Medical Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1183/23120541.00296-2025
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- COPD Foundation
- Sunovion
- Genentech
- National Heart, Lung, and Blood Institute